{"adverse_reactions":["6. ADVERSE REACTIONS 6.1. The most common mild adverse reaction is slight reddening at the injection site due to the mechanical effect of the needle or a superficial skin reaction of mild erythema."],"clinical_pharmacology":["12. CLINICAL PHARMACOLOGY 12.1. Mechanism of Action The medication acts through a low-dose enzymatic mechanism. 12.2. Pharmacodynamics The physiological effects of OMEOFORMULA® 5-VEIN are due to the effects of the ingredients according to their description as listed in the Homeopathic Materia Medica. 12.3. Pharmacokinetics Homeopathic attenuation provides complete bioavability of the active ingredients."],"clinical_studies":["14. CLINICAL STUDIES 14.1. OMEOFORMULA® 5-VEIN formulation is based on classical Homeopathy and each ingredient has been selected according to the homeopathic description as referred to in Materia Medica."],"contraindications":["4. CONTRAINDICATIONS 4.1. There is no history of hypersensitivity to OMEOFORMULA®5-VEIN. However patients with a known hypersensitivity to any ingredient should be tested before use. Make a spot injection (0.1ml) into the forearm and observe for any reactions for 1 hour."],"description":["11. DESCRIPTION OMEOFORMULA® 5-VEIN is a sterile solution made with isotonic sodium chloride solution. Its formulation is based on classical Homeopathy and each ingredient has been selected according to the homeopathic description as referred to in Materia Medica. The firming and toning activity is due to the suis-organ ingredients. These effects are enhanced by the activity of additional ingredients that stimulate the collagen pathway."],"dosage_and_administration":["2. DOSAGE AND ADMINISTRATION 1.1. Treatment for IM application : 1 vial 1-3 times a week according to severity and clinical evolution. 1.2. Treatment using mesotherapy technique : Apply 0.3 ml to each point. Using a 13 mm 30G or a 4 mm 27G needle, make the classic intradermal injection utilizing mesotherapy technique. Sites of application: Tissue area around the blood vessels of the affected region of the body. 1.3. Standard protocol consists of one treatment a week for 5-7 weeks. For prolonged treatments: 2 treatments for the first week, 1 treatment a week for 1 month and then 1 treatment a month are recommended. Discard unused solution . 1.4. Opening of Vials : Use sterile needles and sterile syringe. Do not reuse. Do not use if foreign particles are present. Draw 1 cc of air into syringe, insert needle into vial inject air and withdraw the solution into the syringe."],"dosage_forms_and_strengths":["3. DOSAGE FORMS AND STRENGTHS 3.1. Injectable solution for subcutaneneous, intradermal, or intramuscular administration. Pharmaceutical forms: 2 ml glass vials 3.2. Each ingredient is attenuated according to the procedures stated in the Homeopathic Pharmacopeia of United States. Active ingredients : Aesculus 4X, Apis 8X, Arnica 4X, Collagen 6X, Crotalus 8X, Crotalus 12X, Hamamelis 4X, Hypericum 6X, Lachesis 8X, Myosotis 4X, Solidago 8X, Tabacum 8X, Urtica 8X, Vein 8X, Vein 12X, Vipera 6X. Inactive ingredient : Sterile isotonic sodium chloride solution."],"drug_abuse_and_dependence":["9. DRUG ABUSE AND DEPENDENCE 9.1. No Known."],"drug_interactions":["7. DRUG INTERACTIONS 7.1. None Known."],"effective_time":"20100629","id":"9a4b9d47-8882-466d-a156-95fbb74cffa4","indications_and_usage":["1. INDICATIONS AND USAGE 1.1. Superficial Venous insufficiency 1.2. Varicose veins 1.3. Water retention 1.4. Swollen legs or Lower Extremity Edema."],"information_for_patients":["17. PATIENT COUNSELING INFORMATION 17.1. Patients should be informed of the homeopathic approach and the therapeutic goals of OMEOFORMULA®5-VEIN."],"nonclinical_toxicology":["13. NONCLINICAL TOXICOLOGY 13.1. OMEOFORMULA® 5-VEIN has no level of toxicity due to the attenuation of the ingredients."],"openfda":{},"overdosage":["10. OVERDOSAGE 10.1. No Known."],"package_label_principal_display_panel":["PACKAGE LABEL image of box label"],"references":["15. REFERENCES 15.1. E.Italia, M. De Bellis: Manuale di Omeo-mesoterapia – Guna Ed. 1995 15.2. L. Milani: Weihe e altri Punti tra Agopuntura e Omeopatia. Guna Editore 15.3. H.H.Reckeweg: Homeopathic Materia Medica omeopatica. Aurelia Verlag."],"set_id":"d775e74b-7a11-415d-b2f2-50009366da78","spl_product_data_elements":["OMEOFORMULA 5-VEIN APIS MELLIFERA - ARNICA MONTANA - CROTALUS HORRIDUS HORRIDUS VENOM - HORSE CHESTNUT - HYPERICUM PERFORATUM - LACHESIS MUTA VENOM - MYOSOTIS ARVENSIS - SOLIDAGO VIRGAUREA FLOWERING TOP - SUS SCROFA COLLAGEN - SUS SCROFA VEIN - TOBACCO LEAF - URTICA URENS - VIPERA BERUS VENOM - AESCULUS HIPPOCASTANUM FLOWER - AESCULUS HIPPOCASTANUM FLOWER AESCULUS HIPPOCASTANUM FLOWER APIS MELLIFERA APIS MELLIFERA ARNICA MONTANA ARNICA MONTANA SUS SCROFA COLLAGEN SUS SCROFA COLLAGEN CROTALUS HORRIDUS HORRIDUS VENOM CROTALUS HORRIDUS HORRIDUS VENOM HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK HYPERICUM PERFORATUM HYPERICUM PERFORATUM LACHESIS MUTA VENOM LACHESIS MUTA VENOM MYOSOTIS ARVENSIS MYOSOTIS ARVENSIS SOLIDAGO VIRGAUREA FLOWERING TOP SOLIDAGO VIRGAUREA FLOWERING TOP TOBACCO LEAF TOBACCO LEAF URTICA URENS URTICA URENS SUS SCROFA VEIN SUS SCROFA VEIN VIPERA BERUS VENOM VIPERA BERUS VENOM SODIUM CHLORIDE WATER"],"storage_and_handling":["16. HOW SUPPLIED/STORAGE AND HANDLING 16.1. NDC 17089-409-31 10 glass vials packed in carton box 16.2. NDC 17089-409-32 50 glass vials packed in carton box 16.3. Store at room temperature, 20-25°C (68-77° F). Avoid freezing and excessive heat."],"use_in_specific_populations":["8. USE IN SPECIFIC POPULATIONS 8.1 Pregnancy : Pregnancy category C. Animal reproduction studies have not been conducted with OMEOFORMULA®5-VEIN. OMEOFORMULA®5-VEIN should not be administered to a pregnant woman. 8.2 Nursing mothers : It is not known whether any of the ingredients in OMEOFORMULA®5-VEIN are secreted in human milk. However, since many drugs are secreted in human milk, caution should be exercised when OMEOFORMULA®5-VEIN is administered to a nursing woman. 8.3 Pediatric use : Effectiveness in pediatric patients has not been established. 8.4 Geriatric use : No restrictions."],"version":"2","warnings_and_cautions":["5. WARNINGS AND PRECAUTIONS 5.1. Be sure to disinfect the area before application. Skin disinfection helps avoid infection at the site of administration that can result from saprophytic bacteria (i.e. atypical mycobacteria, staphylococcus genus) that may be present on the skin."]}